August 15, 2013
ViiV Healthcare has received FDA approval for the HIV integrase inhibitor Tivicay (dolutegravir) that it jointly developed with its investor Shionogi, the British drug maker specializing in HIV treatment said on August 12. ViiV Healthcare is a joint venture between...read more